The changing and challenging landscape of the global tobacco epidemic: from vaping to cannabis?
Aims : To raise awareness among the respiratory health care community about the tobacco epidemic changing landscape and nicotine additive products evolution; to inform respiratory healthcare providers about cannabis health effects , from medicinal use to health hazards (focusing on lung health); to update the latest scientific findings and inform the respiratory health care community on the health effects of novel and emergent cannabis, tobacco and nicotine products; to raise awareness for the need to involve respiratory health care providers and researchers, the patients and the public on the cannabis legalization debate
Target audience :
Adult pulmonologist/Clinician, Clinical researcher, General practitioner, Medical Student, Medical Technical Assistant, Nurse, Respiratory critical care physician, Paediatrician, Patient, Physician in Pulmonary Training, Respiratory physiotherapist, Thoracic oncologist, Thoracic surgeon, Respiratory therapist, Journalist
Now it is not only about cigarettes: dual, triple, multiuse of nicotine and cannabis products. What to expect (focus on lung health)
C. Pisinger(Frederiksberg, Denmark)
Paediatric concerns due to expanded cannabis use: how does cannabis affect the immature brain of children and teens”, who gets addicted and what are the clinical mental health implications?
What we know and what we do not know about cannabis health effects: a concern for lung health?
E. Burnham(Boulder, United States of America)
Behind the scenes. The public health concerns of marijuana legalization; from production to marketing and recreational use